Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/107750| Title: | Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax compared with Turbuhaler in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain |
| Author: | Darbà, Josep Ramírez, Gabriela García-Rivero, Juan L. Mayoralas, Sagrario Pascual, José Francisco Vargas, Diego Bijedic, Adi |
| Keywords: | Administració de medicaments Malalties pulmonars obstructives cròniques Tractament tèrmic Economia de la salut Administration of drugs Chronic obstructive pulmonary diseases Heat treatment Medical economics |
| Issue Date: | Feb-2017 |
| Publisher: | Dove Medical Press |
| Abstract: | The objective of this study was to estimate the economic impact of the introduction of DuoResp® Spiromax®, budesonide/formoterol fixed-dose combination (FDC), focusing on an increase in medication adherence due to an enhancement of the inhalation technique for the treatment of COPD patients in Spain and 5 regions including Andalusia, Catalonia, Galicia, Madrid, and Valencia. ... |
| Note: | Reproducció del document publicat a: https://doi.org/10.2147/CEOR.S125301 |
| It is part of: | Clinicoeconomics and Outcomes Research, 2017, vol. 9, num. February, p. 127-137 |
| URI: | http://hdl.handle.net/2445/107750 |
| Related resource: | https://doi.org/10.2147/CEOR.S125301 |
| ISSN: | 1178-6981 |
| Appears in Collections: | Articles publicats en revistes (Economia) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 668396.pdf | 204.4 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
